Pete De Spain | VP, IR |
Troy Wilson | President and CEO |
Marc Grasso | CFO and Chief Business Officer |
Bridget Martell | Acting Chief Medical Officer |
David Ruch | SVP Leerink |
Chris Shibutani | Cowen & Company |
Tyler Van Buren | Piper Sandler |
Jay Olson | Oppenheimer |
Pasquale Sansone | H.C. Wainwright |
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2019 Kura Oncology Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]